Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)

Inclusion Criteria: * Twenty-two years or older at the time of surgery and diagnosed with bilateral cataracts * Able to comprehend and sign a statement of informed consent * Willing and able to complete all required postoperative visits * Calculated Lens Power within the available range for the study IOL's * Planned cataract removal by phacoemulsification * Potential postoperative visual acuity of BCDVA 0.2 LogMAR (20/32) or better in both eyes * Subjects with less than 1.0D of corneal astigmatism * Clear intraocular media other than cataract in the study eye * Preoperative BCDVA worse than 0.2 LogMar (20/32) with or without glare * Pupil size greater or equal to 6.0mm after dilation Exclusion Criteria: * Any corneal abnormality, other than regular corneal astigmatism * Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.2 LogMAR (20/32) * Previous refractive surgery * Amblyopia * Clinical severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy) * Diabetic retinopathy * Extremely shallow anterior chamber, not due to swollen cataract * Microphthalmos * Previous retinal detachment * Previous corneal surgery * Recurrent severe anterior or posterior segment inflammation of unknown etiology * Rubella or traumatic cataract * Iris Neovascularization * Glaucoma (uncontrolled or controlled with medication) * Aniridia * Optic nerve a…